New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 20, 2024 - Alvotech and Teva launched Simlandi (adalimumab-ryvk), an interchangeable biosimilar to AbbVie’s Humira® (adalimumab).
Download PDF
Return to publications
